Your Article Summary
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Annals of Internal Medicine, 06/02/09
Montori VM et al. - Some diabetes guidelines set low glycemic control goals for patients with type 2 diabetes mellitus (such as a hemoglobin A1c level as low as 6.5% to 7.0%) to avoid or delay complications. This review and critique of recent large randomized trials in patients with type 2 diabetes suggest that tight glycemic control burdens patients with complex treatment programs, hypoglycemia, weight gain, and costs and offers uncertain benefits in return. The authors believe clinicians should prioritize supporting well-being and healthy lifestyles, preventive care, and cardiovascular risk reduction in these patients. Glycemic control efforts should individualize hemoglobin A1c targets so that those targets and the actions necessary to achieve them reflect patients' personal and clinical context and their informed values and preferences.
Related Articles
Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09
Relevance Score: 84%
Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09
Relevance Score: 83%
Debating cancer and diabetes in Vienna
Practice Nursing, 11/10/09
Relevance Score: 83%
The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09
Relevance Score: 83%
A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09
Relevance Score: 83%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/11/09
Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09
Obesity in older adults: relationship to functional limitation
Current Opinion in Clinical Nutrition & Metabolic Care, 12/11/09
Today in Internal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient
Journal of General Internal Medicine, 12/11/09
Migraine and Functional Impairment
CNS Drugs, 12/11/09
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09

See Latest Articles